What is the share price of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) today?
The share price of IOLCP as on 16th July 2026 is ₹164.07. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?
The past returns of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share are- Past 1 week: -1.41%
- Past 1 month: 22.42%
- Past 3 months: 91.74%
- Past 6 months: 119.99%
- Past 1 year: 75.63%
- Past 3 years: 121.78%
- Past 5 years: 23.85%
What are the peers or stocks similar to IOL Chemicals and Pharmaceuticals Ltd (IOLCP)?
The peers or stocks similar to IOL Chemicals and Pharmaceuticals Ltd (IOLCP) include:What is the dividend yield % of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?
The current dividend yield of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is 0.61.What is the market cap of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is ₹4815.91 Cr as of 16th July 2026.What is the 52 week high and low of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) share?
The 52-week high of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is ₹179.60 and the 52-week low is ₹67.19.What is the PE and PB ratio of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) stock?
The P/E (price-to-earnings) ratio of IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is 34.99. The P/B (price-to-book) ratio is 2.85.Which sector does IOL Chemicals and Pharmaceuticals Ltd (IOLCP) belong to?
IOL Chemicals and Pharmaceuticals Ltd (IOLCP) belongs to the Materials sector & Commodity Chemicals sub-sector.How to buy IOL Chemicals and Pharmaceuticals Ltd (IOLCP) shares?
You can directly buy IOL Chemicals and Pharmaceuticals Ltd (IOLCP) shares on Tickertape. Simply sign up, connect your demat account and place your order.
IOL Chemicals and Pharmaceuticals Ltd
IOLCP Share Price
NSE₹164.070.98% (-1.63)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
IOLCP Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
IOLCP Performance & Key Metrics
IOLCP Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 34.99 | 2.85 | 0.61% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 24.23 | 3.27 | 1.38% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
IOLCP Company Profile
IOL Chemicals and Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged in manufacturing and selling of organic chemicals and bulk drugs.
SOLARINDS
PE Ratio
99.25
99.25
1Y Return
21.13%
21.13%
Buy Reco %
84.62
84.62
LINDEINDIA
PE Ratio
110.74
110.74
1Y Return
5.59%
5.59%
Buy Reco %
0.00
0.00
PE Ratio
48.51
48.51
1Y Return
40.49%
40.49%
Buy Reco %
0.00
0.00
SUMICHEM
PE Ratio
49.69
49.69
1Y Return
7.68%
7.68%
Buy Reco %
88.89
88.89
DEEPAKNTR
PE Ratio
125.78
125.78
1Y Return
11.11%
11.11%
Buy Reco %
47.06
47.06
IOLCP Sentiment Analysis
IOLCP Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
IOLCP Stock Summary · May 2026
Strong quarter marked by margin expansion and continued reinvestment into capacity and exports. Q4 revenue was INR 619 crore and Q4 EBITDA came in at INR 94 crore with a 15.2% margin, outcomes management attributed to operational efficiencies, improved product mix and higher capacity utilization rather than one‑off inventory gains, and they expect these improved levels to hold for the next one to two quarters. Management emphasised disciplined capital allocation, funding roughly INR 160 crore of FY26 capex from internal accruals and planning about INR 200 crore in FY27 — preferring reinvestment over buybacks — while progressing a greenfield Bhatinda project with remaining approvals expected in 3–4 months and a phased INR 1,200–1,400 crore buildout over 4–5 years. Operational highlights include key pharma lines at ~85%–95% utilization, paracetamol at ~55% installed utilization with targets to reach ~70%–75% in FY27, and a push into regulated export markets (ibuprofen ~45% exported). Management reiterated mid‑to‑high‑teens revenue growth, an FY27 revenue target of ~INR 2,700 crore and an EBITDA margin goal around 14.0%–14.5%.
IOLCP Stock Growth Drivers
IOLCP Stock Growth Drivers
6Stronger financial performance and cash generation
The company delivered its highest-ever quarterly revenue in Q4 FY26 of INR 619 crore (≈+17.4%
Sustained operational efficiency and high capacity utilization
Operational improvements—better product mix, process efficiencies and stronger asset utilization—underpinned recent results, with core finished-dosage
IOLCP Stock Challenges
IOLCP Stock Challenges
7Raw‑material and logistics‑driven cost inflation and price volatility
The company is facing material input‑cost pressure driven by crude‑linked inflation and higher logistics expenses,
Concentrated supply‑chain exposure to China for key starting materials
The firm remains dependent on imports of critical starting materials—most notably key inputs for metformin—from
IOLCP Forecast
IOLCP Forecasts
Price
Revenue
Earnings
IOLCP Share Price Forecast
IOLCP Share Price Forecast
2026
Current
₹164.07
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹164.07
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
IOLCP Company Revenue Forecast
IOLCP Company Revenue Forecast
2026
Current
₹2.34
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹2.34
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
IOLCP Stock EPS (Earnings Per Share) Forecast
IOLCP Stock EPS (Earnings Per Share) Forecast
2026
Current
₹4.69
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹4.69
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
IOLCP
IOLCP
Income
Balance Sheet
Cash Flow
Quarterly Normal View
IOLCP Income Statement
IOLCP Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 528.77 | 511.44 | 509.76 | 532.18 | 527.37 | 532.30 | 559.06 | 574.41 | 585.68 | 621.29 | ||||||||||
Operating & Other expenses | 476.04 | 454.40 | 451.27 | 484.18 | 476.43 | 465.02 | 489.55 | 510.45 | 534.32 | 526.98 | ||||||||||
EBITDA | 52.73 | 57.04 | 58.49 | 48.00 | 50.94 | 67.28 | 69.51 | 63.96 | 51.36 | 94.31 | ||||||||||
| Depreciation/Amortization | 16.34 | 16.43 | 16.82 | 17.94 | 18.68 | 18.55 | 19.77 | 19.99 | 20.18 | 20.29 | ||||||||||
| PBIT | 36.39 | 40.61 | 41.67 | 30.06 | 32.26 | 48.73 | 49.74 | 43.97 | 31.18 | 74.02 | ||||||||||
| Interest & Other Items | 4.30 | 3.41 | 2.15 | 4.12 | 4.46 | 4.03 | 4.23 | 3.48 | 3.63 | 3.21 | ||||||||||
| PBT | 32.09 | 37.20 | 39.52 | 25.94 | 27.80 | 44.70 | 45.51 | 40.49 | 27.55 | 70.81 | ||||||||||
| Taxes & Other Items | 9.01 | 9.58 | 9.55 | 6.79 | 7.27 | 13.28 | 11.58 | 10.52 | 6.97 | 17.65 | ||||||||||
| Net Income | 23.08 | 27.62 | 29.97 | 19.15 | 20.53 | 31.42 | 33.93 | 29.97 | 20.58 | 53.16 | ||||||||||
| EPS | 0.79 | 0.94 | 1.02 | 0.65 | 0.70 | 1.07 | 1.16 | 1.02 | 0.70 | 1.81 |
IOLCP Company Updates
FY 2026FY 2026
Investor Presentation
May 21PDF
Feb 12PDF
Nov 12PDF
Aug 7PDF
IOLCP Stock Peers
IOLCP Past Performance & Peer Comparison
IOLCP Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsCommodity Chemicals
Compare valuation on Screener
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| IOL Chemicals and Pharmaceuticals Ltd | 34.99 | 2.85 | 0.61% |
| Solar Industries India Ltd | 99.25 | 36.59 | 0.06% |
| Linde India Ltd | 110.74 | 15.91 | 0.17% |
| Himadri Speciality Chemical Ltd | 48.51 | 7.65 | 0.11% |
IOLCP Stock Price Comparison
Compare IOLCP with any stock or ETFCompare IOLCP with any stock or ETF
IOLCP
IOLCP Holdings
IOLCP Shareholdings
IOLCP Promoter Holdings Trend
IOLCP Promoter Holdings Trend
IOLCP Institutional Holdings Trend
IOLCP Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 4.06%
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 3.15%
IOLCP Shareholding Pattern
IOLCP Shareholding Pattern
IOLCP Shareholding History
IOLCP Shareholding History
Foreign Institutions
Mutual Funds Invested in IOLCP
Mutual Funds Invested in IOLCP
No mutual funds holding trends are available
Top 2 Mutual Funds holding IOL Chemicals and Pharmaceuticals Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0004% | Percentage of the fund’s portfolio invested in the stock 0.11% | Change in the portfolio weight of the stock over the last 3 months 0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 80/130 (+5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 826/1047 (+11) |
Compare 3-month MF holding change on Screener
smallcases containing IOLCP stock
smallcases containing IOLCP stock
Looks like this stock is not in any smallcase yet.
IOLCP Events
IOLCP Events
IOLCP Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
IOLCP has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.60%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.04 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
IOLCP Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
IOLCP has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.60%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.04 every year
IOLCP Upcoming Dividends
IOLCP Upcoming Dividends
No upcoming dividends are available
IOLCP Past Dividends
IOLCP Past Dividends
Cash Dividend
Ex DateEx DateFeb 17, 2026
Interim
Interim | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Feb 17, 2026
Cash Dividend
Ex DateEx DateFeb 18, 2025
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Feb 18, 2025
Cash Dividend
Ex DateEx DateFeb 16, 2024
Interim
Interim | Div/Share: ₹5.00
Dividend/Share
₹5.00
Ex DateEx Date
Feb 16, 2024
Cash Dividend
Ex DateEx DateFeb 17, 2023
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Feb 17, 2023
Cash Dividend
Ex DateEx DateFeb 15, 2022
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Feb 15, 2022
IOLCP Stock News & Opinions
IOLCP Stock News & Opinions
Articles & Videos
Corporate
Corporate
IOL Chemicals & Pharmaceuticals to conduct AGMIOL Chemicals & Pharmaceuticals announced that the Annual General Meeting(AGM) of the company will be held on 2 September 2026.
1 month agoCapital Market - Live
Earnings
Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit rises 69.19% in the March 2026 quarterNet profit of IOL Chemicals & Pharmaceuticals rose 69.19% to Rs 53.16 crore in the quarter ended March 2026 as against Rs 31.42 crore during the previous quarter ended March 2025. Sales rose 17.37% to Rs 619.45 crore in the quarter ended March 2026 as against Rs 527.78 crore during the previous quarter ended March 2025. For the full year,net profit rose 36.18% to Rs 137.64 crore in the year ended March 2026 as against Rs 101.07 crore during the previous year ended March 2025. Sales rose 11.54% to Rs 2319.06 crore in the year ended March 2026 as against Rs 2079.21 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales619.45527.78 17 2319.062079.21 12 OPM %14.9311.89 -11.609.73 - PBDT91.1063.25 44 275.80209.95 31 PBT70.8144.70 58 195.57137.96 42 NP53.1631.42 69 137.64101.07 36 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
IOL Chemicals & Pharmaceuticals to table resultsIOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 20 May 2026.
2 months agoCapital Market - Live
Spotlight
Spotlight
IOL Chemicals scales up chemical manufacturing capacitiesThe company has enhanced the manufacturing capacity of Ethyl Acetate from 1,00,000 MT per annum to 1,20,000 MT per annum with a capex of about Rs 4 crore. The additional capacity of 20,000 MTPA was completed on 2 March 2026. The expansion has been undertaken to cater to sustained demand growth across various sectors and to improve margin realisation through optimal operating leverage. In addition, the company has expanded the manufacturing capacity of Acetic Anhydride from 25,000 MTPA to 32,000 MTPA. The project entails a capital expenditure of about Rs 5.71 crore. The existing facility was operating at above 90% capacity utilisation prior to the expansion. The additional capacity of 7,000 MTPA was commissioned on 2 March 2026. This expansion is aimed at optimising captive consumption as well as increasing merchant sales. IOL Chemicals & Pharmaceuticals is one of the leading pharmaceutical (APIs) Companies and a significant player in the specialty chemicals space with world-class facilities. IOLCP has a wide presence across major therapeutic categories like pain management, anti-convulsants, anti-diabetes, anti-cholesterol and anti-platelets. The company's consolidated net profit rose marginally by 0.2% to Rs 20.58 crore, while net sales increased 10.9% to Rs 580.39 crore in Q3 FY26 compared with Q3 FY25. The counter dropped 1.77% to Rs 70 on the BSE.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit rises 0.24% in the December 2025 quarterNet profit of IOL Chemicals & Pharmaceuticals rose 0.24% to Rs 20.58 crore in the quarter ended December 2025 as against Rs 20.53 crore during the previous quarter ended December 2024. Sales rose 10.91% to Rs 580.39 crore in the quarter ended December 2025 as against Rs 523.30 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales580.39523.30 11 OPM %9.878.96 - PBDT58.9446.48 27 PBT38.7627.80 39 NP20.5820.53 0 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Board of IOL Chemicals & Pharmaceuticals recommends interim dividendIOL Chemicals & Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 11 February 2026, inter alia, have recommended the interim dividend of Rs 1 per equity Share (i.e. 50%) , subject to the approval of the shareholders.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
IOL Chemicals & Pharmaceuticals to discuss resultsIOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
IOL Chemicals & Pharmaceuticals consolidated net profit rises 56.50% in the September 2025 quarterNet profit of IOL Chemicals & Pharmaceuticals rose 56.50% to Rs 29.97 crore in the quarter ended September 2025 as against Rs 19.15 crore during the previous quarter ended September 2024. Sales rose 7.95% to Rs 567.53 crore in the quarter ended September 2025 as against Rs 525.75 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales567.53525.75 8 OPM %10.067.91 - PBDT60.4843.88 38 PBT40.4925.94 56 NP29.9719.15 57 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
IOL Chemicals & Pharmaceuticals schedules board meetingIOL Chemicals & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
IOL Chemicals receives CEP certificate for Sitagliptin Phosphate MonohydrateIOL Chemicals & Pharmaceuticals announced that the European Directorate for the Quality of Medicines & Health Care (EDQM) has issued a Certificate of Suitability for Company's API product 'Sitagliptin Phosphate Monohydrate' on 27 October 2025. Sitagliptin Phosphate Monohydrate is an oral antidiabetic medication used to control high blood sugar levels. Powered by Capital Market - Live
8 months agoCapital Market - Live
In last 6 months, promoter holding in the company has increased by 9.65%
Pledged promoter holdings is insignificant